Actively Recruiting
Evaluation of Precision Partial Intersphincteric Resection Compared to Traditional Surgery for Ultra-low Rectal Cancer
Led by First Affiliated Hospital of Wenzhou Medical University · Updated on 2026-09-30
100
Participants Needed
1
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying a new surgical technique called Precision Partial Intersphincteric Resection PPISR for treating patients with ultra-low rectal cancer. This study aims to develop a standardized procedure for PPISR and evaluate its surgical safety, functional benefits such as anal function and quality of life, and oncological effectiveness compared with the traditional Intersphincteric Resection ISR surgery. Participants are randomly assigned to one of two groups the experimental group undergoing the PPISR procedure or the control group receiving the traditional ISR procedure. Both surgeries involve precise removal of tumor tissue and affected areas, with PPISR aiming to preserve more of the internal anal sphincter and normal intestinal tissue. The study includes detailed surgical steps and postoperative monitoring. During the study, participants will be assessed for anal function using the Wexner Score at 3 and 6 months after surgery, quality of life at 1 year using the EORTC QLQ-C30 questionnaire, and local cancer recurrence through abdominal contrast-enhanced MRI at 3 years. Additional measures include blood loss during surgery, margin status from pathology, complications up to 3 months post-surgery, and length of hospital stay. Participants will be followed for several years to monitor outcomes and safety.
CONDITIONS
Brief Title
Application of Precision Partial Intersphincteric Resection (PPISR)
Research Team
S
shaotang li
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here